Post-operative CT Follow up After Nellix Endoprosthesis Implantation

Sponsor
Rijnstate Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT02440113
Collaborator
(none)
50
8

Study Details

Study Description

Brief Summary

Multicenter retrospective CT follow up after aortic aneurysm repair using Nellix Endoprosthesis.

Condition or Disease Intervention/Treatment Phase
  • Device: Nellix

Detailed Description

Rationale:

In patients with abdominal aortic aneurysms the Nellix Endoprosthesis aims to reduce post-operative complications and subsequent re-intervention rates. Using two stents covered with two polymer filled endobags used for sealing and excluding the aneurysm sac. Preliminary results show promising results in reducing these complications. The new endoprosthesis is not only different in treatment but also in follow up imaging. To date it is unknown how the stent, polymer filled endobags and aneurysm appear in CT imaging in short and long term follow up.

Objective:

To assess and describe the normal computed tomography (CT) appearance at 30 days and 1 year after implantation of the Nellix Endoprosthesis.

Study population:

Approximately a total of 100 patients who underwent endovascular aneurysm repair using Nellix endoprosthesis in three different hospitals. The population is comprised of approximately fifty patients from Rijnstate Ziekenhuis Arnhem and twenty-five each from St. Antonius Nieuwegein and St. Elisabeth Tilburg.

Design and methods:

The study is designed as a multicenter retrospective cohort. Using CT-scans from regular follow up dates (30 days and 1 year) imaging will be retrospectively assessed using medical imaging software. Main study endpoints are defined as followed:

  1. Changes in the infrarenal neck morphology (below the renal arteries)

  2. Changes in the thrombus in the aneurysm sac

  3. Changes in the aneurysm wall and geometry

  4. Changes in the cobalt-chromium stent and their lumen

  5. Changes in the polymer-filled endobags Using anonymous patient data a database will be created an securely stored. Patient consent for study participation will be attained before accessing patient files.

Nature and extent of the burden and risk associated with participation, benefit and group relatedness:

The study will not bring an extra burden or risk for patients participating. Patients are encouraged to participate to improve insight for patients with the same disease and might improve health care in the future for this group of patients.

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Post-operative CT Follow up Measurement After Nellix Endoprosthesis Implantation in Patients With Abdominal Aortic Aneurysms.
Study Start Date :
Dec 1, 2014
Actual Primary Completion Date :
Aug 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Nellix

Patients with endovascular Nellix repair

Device: Nellix
Nellix Implantation

Outcome Measures

Primary Outcome Measures

  1. Changes in the infrarenal neck morphology (below the renal arteries) [1 year]

  2. Changes in the thrombus in the aneurysm sac [1 year]

  3. Changes in the aneurysm wall and geometry [1 year]

  4. Changes in the cobalt-chromium stent and their lumen [1 year]

  5. Changes in the polymer-filled endobags Using anonymous patient data a database will be created an securely stored. Patient consent for study participation will be attained before accessing patient files [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who underwent endovascular abdominal aneurysm repair using the Nellix endoprosthesis
Exclusion Criteria:
  • No specific exclusion criteria

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Rijnstate Hospital

Investigators

  • Principal Investigator: Michel Reijnen, MD, PhD, Rijnstate Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michel Reijnen, M.D., PhD, Rijnstate Hospital
ClinicalTrials.gov Identifier:
NCT02440113
Other Study ID Numbers:
  • WP-14-857
First Posted:
May 12, 2015
Last Update Posted:
Jul 15, 2016
Last Verified:
Jul 1, 2016
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 15, 2016